No head-to-head trial? Simulate the missing arms

PharmacoEconomics

Volumn 28, Issue 10, 2010, Pages 957-967

  Caro, J Jaime ^a,b   Ishak, K Jack ^c  

^a MCGILL UNIVERSITY   (Canada)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c UNITED BIOSOURCE CORPORATION   (Canada)

Author keywords

Clinical trial design; Meta analysis; Treatment outcome

Indexed keywords

CALIBRATION; COMPARATIVE EFFECTIVENESS; COMPUTER SIMULATION; DATA ANALYSIS; EVIDENCE BASED MEDICINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SIMULATED TREATMENT COMPARISON;

CLINICAL TRIALS AS TOPIC; COMPARATIVE EFFECTIVENESS RESEARCH; COST-BENEFIT ANALYSIS; HUMANS; MODELS, ECONOMIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77956548296     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11537420-000000000-00000     Document Type: Review

References (19)

1. Reinhardt UE. An information infrastructure for the phar-maceutical market. Health Aff (Millwood) 2004; 23 (1): 107-112
2. Wilensky GR. Developing a center for comparative effec-tiveness information. Health Aff (Millwood) 2006; 25 (6): w572-85
3. Schneeweis S. Developments in post-marketing compara-tive effectiveness research. Clin Pharmacol Ther 2007; 82: 143-156
4. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003; 290 (12): 1624-1632
5. Ades AE, Sculpher M, Sutton A, et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics 2006; 24 (1): 1-19
6. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004; 23 (20): 3105-3124
7. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002; 21 (16): 2313-2324
8. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998; 316 (7135): 894-898
9. Non-small Cell Lung Cancer Collaborative Group. Chemo-therapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899-909
10. Moore RA, McQuay HJ. Single-patient data meta-analysis of 3453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics. Pain 1997; 69 (3): 287-294
11. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992; 327 (23): 1618-1624
12. Tugwell P, Knottnerus JA. Advantages of individual patient data analysis in systematic reviews. J Clin Epidemiol 2010; 63 (3): 233-234
13. Van Walraven C. Individual patient meta-analysis: rewards and challenges. J Clin Epidemiol 2010; 63 (3): 235-237
14. Caro JJ. Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconomics 2005; 23 (4): 323-332
15. Kelton WD, Sadowski RP, Sturrock DT, editors. Simula-tion with Arena. 4th ed. New York: McGraw-Hill, 2007
16. Caro JJ, Moller J, Getsios D. Discrete event simulation: the preferred technique for health economic evaluations? Value Health. In press
17. Song F, Altman DG, Glenny AM, et al. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003; 326 (7387): 472
18. Ades AE, Lu G. Assessing evidence inconsistency in mixed treatment comparisons. JASA 2006; 101 (474): 447-459
19. Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Making 2005; 25 (6): 646-54